Company intelligence / Profile preview

Shanghai Modern Traditional Chinese Medicine

Shanghai, Shanghai, China
Ownership
Private
Development stage
Other
01

Overview

Shanghai Baheal Pharmaceutical Co., Ltd. (formerly Shanghai Modern Traditional Chinese Medicine Co., Ltd.) is an innovative pharmaceutical company specializing in the modernization of traditional Chinese medicine (TCM) and high-end sustained-release formulations. The company's flagship product, Fuzheng Huayu, is a leading botanical drug for liver fibrosis and the first TCM compound to complete Phase II clinical trials in the United States. Its pipeline also includes Qishe Pills for cervical spondylosis, Annian Granules for menopausal syndrome, and Nida, a once-daily osmotic pump metformin formulation for type 2 diabetes. In July 2024, the company was acquired by Qingdao Baheal Pharmaceutical Co., Ltd. (SZ.301015) for 880 million RMB, integrating its advanced manufacturing and R&D capabilities into Baheal's commercialization platform.

Therapeutic areas
Infectious DiseasesNeurologyEndocrinologyWomen's HealthGastroenterology
Modalities
Botanical extractHerbal medicineSmall molecule
Industry
Pharma
02

Partnerships

Shanghai University of Traditional Chinese MedicineEast China University of Science and TechnologyShuguang Hospital

Beyond the preview

Go deeper on Shanghai Modern Traditional Chinese Medicine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Modern Traditional Chinese Medicine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call